Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • April 25, 2019 9:33 AM | Anonymous

    April 24, 2019, HemOnc Today  

    Screening with 3-D digital breast tomosynthesis appeared associated with increases in both specificity and proportion of breast cancers detected with better prognosis than two-dimensional digital mammography, according to results of a retrospective observational study published in JAMA Oncology. The findings were especially true for a subgroup of women age 40 to 49.  

    Read more.

  • April 24, 2019 8:38 AM | Anonymous

    April 24, 2019, HealthDay News 

    A type of cervical cancer that's less sensitive to Pap testing is increasing among white women in the United States, new research shows. An overall decline in cervical cancer rates in recent decades has been driven by decreases in squamous cell carcinomas. Most of the rest of cervical cancer cases are adenocarcinomas, which are less likely to be detected by Pap testing and are mainly caused by the human papillomavirus (HPV).

    Read more.

  • April 24, 2019 8:32 AM | Anonymous

    April 24, 2019, Medgadget 

    Preeclampsia is one of the most common serious maladies that pregnant women encounter. It is a poorly understood condition with symptoms such as high blood pressure, proteinuria, and headaches, potentially even leading to seizures. The treatment options for preeclampsia are still very limited, mostly confined to hypertension medications, bed rest, and birthing the baby, which is essentially a cure for the disease. A new option has just been given Breakthrough Device Designation by the U.S. Food and Drug Administration. 

    Read more.

  • April 22, 2019 9:55 AM | Anonymous

    April 22, 2019, Medical News Today 

    Leucine, an amino acid that the body needs for making protein, appears to have a surprising role in the development of resistance to tamoxifen in breast cancer that tests positive for the estrogen receptor. Scientists from Harvard Medical School recently made this "unexpected" discovery about estrogen receptor-positive breast cancer in a study conducted with colleagues from other research centers. 

    Read more.

  • April 22, 2019 9:54 AM | Anonymous

    April 22, 2019, Contemporary Clinic  

    The first and only FDA-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral daily capsule for the treatment of moderate-to-severe vasomotor symptoms, BijuvaTM, from Therapeutics MD is now commercially available in the U.S., according to a press release from the company. Bijuva offers a proven balance of bio-identical estradiol combined with bio-identical progesterone to reduce risk to the endometrium in women with a uterus, according to the release. 

    Read more.

  • April 19, 2019 11:46 AM | Anonymous

    April 19, 2019, MedPage Today  

    A type of cervical cancer often missed by Pap testing was seen at increasing rates over the past 15 years in the U.S., whereas rates of the most common histology decreased, a review of a cancer database showed. 

    Read more.

  • April 19, 2019 11:43 AM | Anonymous

    April 19, 2019, Infectious Disease News 

    The monoclonal antibody UB-421 “demonstrated unprecedented and sustained” virologic suppression in the absence of ART among people with HIV during a nonrandomized, open-label, phase 2 clinical study, according to findings published April 17 by The New England Journal of Medicine.

    Read more.


  • April 16, 2019 12:52 PM | Anonymous

    April 16, 2019, Lupin

    Lupin Pharmaceuticals Medical Affairs is looking for PAs in ObGyn and Women’s Health to participate in an advisory board meeting on the topic of bacterial vaginosis (BV).  This meeting will take place during, but not affiliated with, the AAPA 2019 Annual Meeting in Denver.  An honorarium will be offered for your time.

    The meeting will be held Tuesday, May 21, 6-8pm at the Hyatt Regency Denver. (Dinner will be served)

    Please contact Elizabeth Sarkar at sarkar@ja-online.com if you are interested or for more information.


  • April 15, 2019 11:46 AM | Anonymous

    April 15, 2019
    Submitted by APAOG Publications Chair Heather Adams 


    Endocrine Society Guidelines 

    The Endocrine Society recently used clinical trial data and clinical expertise to formulate new guidelines for the treatment of postmenopausal osteoporosis. 

    Read more.

    PAs and Medical Malpractice Claims

    A new trend has been identified; Physician Assistants are being increasingly targeted or singled out by the Personal Injury Bar for medical malpractice claims.  

    Read more. 

    FDA Approves expanded us of Gardasil9® 

    It’s official! The FDA has approved the expanded age indication for Gardasil 9®, which is now indicated for females and males from age 9 years to 45 years of age.  

      

    Read more.


  • April 15, 2019 9:42 AM | Anonymous

    April 15, 2019, HemOnc Today 

    HPV infection drove a recent increase in glottic carcinoma incidence among individuals aged 30 years and younger, according to results of a retrospective study published in in Annals of Otology, Rhinology & Laryngology. 

    Read more.


Powered by Wild Apricot Membership Software